Procyon's average Accounts Receivable for the
three
months ended in Jun. 2024 was $0.50 Mil. Procyon's Revenue for the
three
months ended in Jun. 2024 was $1.41 Mil.
Hence, Procyon's Days Sales Outstanding for the
three
months ended in Jun. 2024 was 32.13.
The historical rank and industry rank for Procyon's Days Sales Outstanding or its related term are showing as below:
PCYN'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.78 Med: 34.88 Max: 42.3
Current: 35.63
During the past 13 years, Procyon's highest Days Sales Outstanding was 42.30. The lowest was 30.78. And the median was 34.88.
PCYN's Days Sales Outstanding is not ranked
in the Drug Manufacturers industry.
Industry Median: 72.25
vs PCYN: 35.63
Procyon's Days Sales Outstanding
declined
from Jun. 2023 (38.22) to Jun. 2024 (32.13).
Procyon Days Sales Outstanding Historical Data
The historical data trend for Procyon's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Procyon's Days Sales Outstanding
For the Drug Manufacturers - Specialty & Generic subindustry, Procyon's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Procyon's Days Sales Outstanding Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Procyon's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Procyon's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procyon (OTCPK:PCYN) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Procyon Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Procyon's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PCYN has been successfully added to your 